In breast cancer, claudin-7 expression was also found to be decreased and inversely correlated with tumor grade and metastatic disease [17],[18], although there is evidence that claudin-7 may become re-expressed in metastases [20],[21]. This evidence concerns the gene CLDN7 and breast cancer.